Anthelmin Plus 50 mg/144 mg/150 mg Kautabletten für Hunde
Anthelmin Plus 50 mg/144 mg/150 mg Kautabletten für Hunde
Authorised
- Praziquantel
- Pyrantel embonate
- Febantel
Product identification
Medicine name:
Anthelmin Plus 50 mg/144 mg/150 mg Kautabletten für Hunde
Active substance:
- Praziquantel
- Pyrantel embonate
- Febantel
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Praziquantel50.00/milligram(s)1.00Tablet
-
Pyrantel embonate144.00/milligram(s)1.00Tablet
-
Febantel150.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AA51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Available in:
-
Germany
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- TAD Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- TAD Pharma GmbH
- Krka-Farma d.o.o.
- KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 401326.00.00
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 28/05/2025
2401326-parde-20110511.pdf
German (PDF)
Download Published on: 2/09/2024